Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial. Lorusso D, Oaknin A, Borges GS, Damian F, et al. Gynecol Oncol 2025;196:28-35.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lorusso D, Oaknin A, Borges GS, Damian F, et al. Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial. Gynecol Oncol 2025;196:28-35.
PMID: 40154184